Home › Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca
 

Keywords :   


Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca

2014-01-03 11:53:31| Biotech - Topix.net

Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca .

Tags: program transfers inhibitor astrazeneca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.11JELEEBOX
26.11
26.11222CB
26.11BOSS ( ) BB-1X Bass Driver
26.1112010 re0827-141
26.11
26.11 2021 EDITION
26.11DVD
More »